SCHEDULE: Vicarious Surgical: Innovation Endeavors Sells Stake

Sentiment:

Beneficial Ownership Filing Amendment 6 April 2026 7:01 PM

Innovation Endeavors III LP and Dror Berman have reduced their beneficial ownership in Vicarious Surgical Inc. to below 5% after a series of stock sales.

Summary

Innovation Endeavors III LP and Dror Berman have filed an amendment to their Schedule 13D, reporting a decrease in their beneficial ownership of Vicarious Surgical Inc. Class A Common Stock.
As of April 6, 2026, their combined beneficial ownership has fallen below the 5% threshold.
This reduction is due to multiple open market sales of shares conducted between March 20, 2026, and April 6, 2026.
The total number of shares beneficially owned by the reporting persons is now 221,038, representing 3.4% of the outstanding Class A common stock.
The filing indicates that the reporting persons are no longer considered beneficial owners of more than five percent of the Class A common stock as of April 6, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the substantial reduction in ownership by a key investor, which may signal a lack of confidence or a strategic shift away from the company.

Negatives

Significant sales of company stock by a major holder, indicating a potential reduction in confidence or strategic shift.
The weighted average sales price for shares sold on April 6, 2026, was $0.82, suggesting a declining stock price during the sale period.

Risks

The substantial sales by Innovation Endeavors could signal concerns about the company's future performance or strategic direction, potentially impacting investor sentiment.
Further sales by this entity could exert downward pressure on the stock price.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from management regarding future performance. The primary focus is on reporting a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that significant stake reductions by major investors, especially venture capital firms like Innovation Endeavors, can be interpreted in various ways, including portfolio rebalancing, realization of gains, or potential concerns about a company's near-term prospects within the competitive surgical robotics landscape.

Stakeholder Impact

Shareholders may view the significant sale by Innovation Endeavors as a negative signal, potentially impacting share price and investor confidence.
The reduction in ownership by a venture capital firm could affect the perception of institutional support for the company.

Next Steps

The reporting persons will continue to monitor their beneficial ownership levels and may adjust their holdings further.
The market will likely observe future trading activity of Vicarious Surgical Inc. in light of this ownership change.

Key Dates

Date	Description
2021-09-28	Original Schedule 13D filing date.
2026-03-16	Date as of which shares of Class A common stock outstanding were reported as 6,470,228.
2026-03-20	First reported sale of shares in this amendment.
2026-03-23	Date of sale of 25,000 shares.
2026-03-24	Date of sale of 1,001 shares.
2026-03-25	Date of sale of 25 shares.
2026-03-26	Date of sale of 3,013 shares.
2026-03-27	Date of sale of 1,000 shares.
2026-03-30	Date of sale of 4,595 shares.
2026-03-31	Date of sale of 1,449 shares.
2026-04-01	Date of sale of 1,487 shares.
2026-04-02	Date of sale of 53,868 shares and the event which requires filing of this statement.
2026-04-06	Date of sale of 136,682 shares and the date reporting persons ceased to be beneficial owners of more than five percent.
2026-04-06	Date of certification and filing of Amendment No. 1.

Recommendation

hold

While the significant sale by a major holder is a negative signal, the filing itself does not provide enough operational or financial data to warrant a sell recommendation. It primarily reports a change in ownership. A 'hold' recommendation allows for further observation of the company's performance and market reaction to this ownership shift.

Keywords

Vicarious Surgical, Schedule 13D, Innovation Endeavors, Dror Berman, Beneficial Ownership, Stock Sale, SEC Filing, Class A Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.